<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>PROPYLTHIOURACIL- propylthiouracilÂ tabletÂ </strong><br>Rebel Distributors Corp.<br></p></div>
<h1>PROPYLTHIOURACIL <br>TABLETS, USP</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_1012a088-2224-43c7-b180-cb87a6a0bf6e"></a><a name="section-1"></a><p></p>
<p class="First">Rev. 08/11</p>
<p><span class="Bold">Rx Only</span></p>
</div>
<div class="Warning">
<a name="id_cff73c31-8e73-4626-bb68-b3f277b577a0"></a><a name="section-2"></a><p></p>
<h1>BOXED WARNING</h1>
<p class="First"><span class="Bold">WARNING:</span> Severe <span class="product-label-link" type="condition" conceptid="4352876" conceptname="Liver damage">liver injury</span> and <span class="product-label-link" type="condition" conceptid="4026032" conceptname="Acute hepatic failure">acute liver failure</span>, in some cases fatal, have been reported in patients treated with propylthiouracil. These reports of hepatic reactions include cases requiring liver transplantation in adult and pediatric patients.</p>
<p>Propylthiouracil should be reserved for patients who can not tolerate methimazole and in whom radioactive iodine therapy or surgery are not appropriate treatments for the management of <span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">hyperthyroidism</span>.</p>
<p>Because of the risk of fetal abnormalities associated with methimazole, proplythiouracil may be the treatment of choice when an antithyroid drug is indicated during or just prior to the first trimester of pregnancy (see <span class="Bold">Warnings and Precautions</span>).</p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="i4i_description_id_cca49435-eaa1-4ad6-84db-b7bb21e947af"></a><a name="section-2"></a><p></p>
<h1>DESCRIPTION:</h1>
<p class="First">Propylthiouracil (6-propyl-2-thiouracil) is one of the thiocarbamide compounds. It is a white, crystalline substance that has a bitter taste and is very slightly soluble in water.</p>
<p>Propylthiouracil is an antithyroid drug administered orally. The structural formula is:</p>
<div class="Figure"><img alt="Structural Formula" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=ff603c99-6620-4945-acdc-c9150b6f77d4&amp;name=ff603c99-6620-4945-acdc-c9150b6f77d4-01.jpg"></div>
<p>Each tablet contains propylthiouracil 50 mg and the following inactive ingredients: anhydrous lactose, magnesium stearate, microcrystalline cellulose, pregelatinized starch, and sodium starch glycolate.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="i4i_clinical_pharmacology_id_b4787538-52d3-4cb4-8683-b4f3000851e5"></a><a name="section-3"></a><p></p>
<h1>CLINICAL PHARMACOLOGY:</h1>
<p class="First">Propylthiouracil inhibits the synthesis of thyroid hormones and thus is effective in the treatment of <span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">hyperthyroidism</span>. The drug does not inactivate existing thyroxine and triodothyronine that are stored in the thyroid or circulating in the blood, nor does it interfere with the effectiveness of thyroid hormones given by mouth or by injection. Propylthiouracil inhibits the conversation of thyroxine to triiodothyronine to peripheral tissues and may therefore be an effective treatment for <span class="product-label-link" type="condition" conceptid="133436" conceptname="Thyrotoxic crisis">thyroid storm</span>.</p>
<p>Propylthiouracil is readily absorbed and is extensively metabolized. Approximately 35% of the drug is excreted in the urine, in intact and in conjugated forms, within 24 hours.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="i4i_indications_id_56f3d9c3-2f56-4b84-9fa8-5901e94b57a0"></a><a name="section-4"></a><p></p>
<h1>INDICATIONS AND USAGE:</h1>
<p class="First">Propylthiouracil is indicated:</p>
<ul>
<li>in patients with Graves' disease with <span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">hyperthyroidism</span> or toxic multinodular <span class="product-label-link" type="condition" conceptid="135772" conceptname="Goiter">goiter</span> who are intolerant of methimazole and for whom surgery or radioactive iodine therapy is not an appropriate treatment option.</li>
<li>to ameliorate symptoms of <span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">hyperthyroidism</span> in preparation forÂ thyroidectomy or radioactive iodine therapy in patients who are intolerant of methimazole.</li>
</ul>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="i4i_contraindications_id_0a260d16-999a-45a3-b601-fcb59e617d5f"></a><a name="section-5"></a><p></p>
<h1>CONTRAINDICATIONS:</h1>
<p class="First">Propylthiouracil is contraindicated in patients who have demonstrated <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to the drug or any of the other product components.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="i4i_warnings_id_504ebf66-540f-44b4-a05f-b440aae80dd0"></a><a name="section-6"></a><p></p>
<h1>WARNINGS:</h1>
<p class="First">.</p>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_b42c71c6-1fab-417d-9816-3cf2dda8f951"></a><a name="section-6.1"></a><p></p>
<h2>Liver Toxicity</h2>
<p class="First"><span class="product-label-link" type="condition" conceptid="4352876" conceptname="Liver damage">Liver injury</span> resulting in <span class="product-label-link" type="condition" conceptid="4245975" conceptname="Hepatic failure">liver failure</span>, liver transplantation, or <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span>, has been reported with propylthiouracil therapy in adult and pediatric patients. No cases of <span class="product-label-link" type="condition" conceptid="4245975" conceptname="Hepatic failure">liver failure</span> have been reported with the use of methimazole in pediatric patients. For this reason, propylthiouracil is not recommended for pediatric patients except when methimazole is not well-tolerated and surgery or radioactive iodine therapy are not appropriate therapies.</p>
<p>There are cases of <span class="product-label-link" type="condition" conceptid="4352876" conceptname="Liver damage">liver injury</span>, including liver faillure and <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span>, in women treated with propylthiouracil during pregnancy. Two reports of <span class="Italics">in utero </span>exposure with <span class="product-label-link" type="condition" conceptid="4245975" conceptname="Hepatic failure">liver failure</span> and <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span> of a newborn have been reported. The use of an alternative antithyroid medication (e.g., methimazole) may be advisable following the first trimester of pregnancy (see <span class="Bold">PRECAUTIONS, Pregnancy</span>).</p>
<p>Biochemical monitoring of liver function (bilirubin, alkaline phosphatase) and hepatocellular integrity (ALT, AST) is not expected to attenuate the risk of severe <span class="product-label-link" type="condition" conceptid="4352876" conceptname="Liver damage">liver injury</span> due to its rapid and unpredictable onset. Patients should be informed of the risk of <span class="product-label-link" type="condition" conceptid="4245975" conceptname="Hepatic failure">liver failure</span>. Patients should be instructed to report any symptoms of hepatic dysfunction (<span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">anorexia</span>, <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span>, <span class="product-label-link" type="condition" conceptid="194175" conceptname="Left upper quadrant pain">right upper quadrant pain</span>, etc.) particularly in the first six months of therapy. When these symptoms occur, propylthouracil should be discontinued immediately and liver function tests and ALT and AST levels obtained.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_2dde8a1f-1df2-42ad-b21b-09603c624261"></a><a name="section-6.2"></a><p></p>
<h2><span class="product-label-link" type="condition" conceptid="440689" conceptname="Agranulocytosis">Agranulocytosis</span></h2>
<p class="First"><span class="product-label-link" type="condition" conceptid="440689" conceptname="Agranulocytosis">Agranulocytosis</span> occurs in approximately 0.2% to 0.5% of patients and is a potentially llife-threatening side effect of propylthiouracil therapy. <span class="product-label-link" type="condition" conceptid="440689" conceptname="Agranulocytosis">Agranulocytosis</span> typically occurs within the first 3 months of therapy. Patients should be instructed to immediately report any symptoms suggestive of <span class="product-label-link" type="condition" conceptid="440689" conceptname="Agranulocytosis">agranulocytosis</span>, such as <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span> or <span class="product-label-link" type="condition" conceptid="26711" conceptname="Chronic pharyngitis">sore throat</span>. <span class="product-label-link" type="condition" conceptid="435224" conceptname="Leukopenia">Leukopenia</span>, <span class="product-label-link" type="condition" conceptid="432870" conceptname="Thrombocytopenic disorder">thrombocytopenia</span>, and <span class="product-label-link" type="condition" conceptid="137829" conceptname="Aplastic anemia">aplastic anemia</span> (<span class="product-label-link" type="condition" conceptid="432881" conceptname="Pancytopenia">pancytopenia</span>) may also occur. Propylthiouracil should be discontinued if <span class="product-label-link" type="condition" conceptid="440689" conceptname="Agranulocytosis">agranulocytosis</span>, <span class="product-label-link" type="condition" conceptid="137829" conceptname="Aplastic anemia">aplastic anemia</span> (<span class="product-label-link" type="condition" conceptid="432881" conceptname="Pancytopenia">pancytopenia</span>), <span class="product-label-link" type="condition" conceptid="4012393" conceptname="Antiproteinase 3 antibody">ANCA</span>-positive <span class="product-label-link" type="condition" conceptid="4137275" conceptname="Vasculitis">vasculitis</span>, <span class="product-label-link" type="condition" conceptid="194990" conceptname="Inflammatory disease of liver">hepatitis</span>, <span class="product-label-link" type="condition" conceptid="4119786" conceptname="Interstitial lung disease">interstitial pneumonitis</span>, <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>, or <span class="product-label-link" type="condition" conceptid="4270887" conceptname="Erythroderma">exfoliative dermatitis</span> is suspected, and the patient's bone marrow indices should be obtained.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_5f0ec13a-8ee3-4373-9cf2-7fd19f804e0c"></a><a name="section-6.3"></a><p></p>
<h2><span class="product-label-link" type="condition" conceptid="140673" conceptname="Hypothyroidism">Hypothyroidism</span></h2>
<p class="First">Propylthiouracil can cause <span class="product-label-link" type="condition" conceptid="140673" conceptname="Hypothyroidism">hypothyroidism</span> necessitating routine monitoring of TSH and free T4 levels with adjustments in dosing to maintain a euthyroid state. Because the drug readily crosses placental membranes, propylthiouracil can cause fetal <span class="product-label-link" type="condition" conceptid="135772" conceptname="Goiter">goiter</span> and <span class="product-label-link" type="condition" conceptid="133728" conceptname="Congenital hypothyroidism">cretinism</span> when administered to a pregnant woman (see <span class="Bold">PRECAUTIONS, Pregnancy</span>).</p>
</div>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="i4i_precautions_id_e0c78c10-4815-4d94-b025-ede5d6d8cd8c"></a><a name="section-7"></a><p></p>
<h1>PRECAUTIONS:</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="i4i_precautions_general_id_f689d25f-f577-4760-8d0e-614bd1cd44f7"></a><a name="section-7.1"></a><p></p>
<h2>General</h2>
<p class="First">Patients should be instructed to report any symptoms of hepatic dysfunction (<span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">anorexia</span>, <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span>, jau7ndice, light colored stools, dark urine, <span class="product-label-link" type="condition" conceptid="194175" conceptname="Left upper quadrant pain">right upper quadrant pain</span>, etc.), particularly in the first six months of therapy. When these symptoms occur, measurement should be made of liver function (bilirubin, alkaline phosphatase) and hepatocellular integrity (ALT/AST levels).</p>
<p>Patients who receive propylthiouracil should be under close surveillance and should be counseled regarding the necessity of reportingÂ any evidence of illness, particularly <span class="product-label-link" type="condition" conceptid="26711" conceptname="Chronic pharyngitis">sore throat</span>, <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">skin eruptions</span>, <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>, <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, or <span class="product-label-link" type="condition" conceptid="4272240" conceptname="Malaise">general malaise</span>. In such cases, white blood cell and differential counts should be obtained to determine whether <span class="product-label-link" type="condition" conceptid="440689" conceptname="Agranulocytosis">agranulocytosis</span> has developed. Particular care should be exercised with patients who are receiving concomitant drugs known to be associated with <span class="product-label-link" type="condition" conceptid="440689" conceptname="Agranulocytosis">agranulocytosis</span>.</p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="i4i_info_patients_id_987eda37-c4ac-4d02-bebc-753a10199303"></a><a name="section-7.2"></a><p></p>
<h2>Information for Patients</h2>
<p class="First">Patients should be advised that if they become pregnantÂ or intend to become pregnant white taking an antithyroid drug, they should contact their physician immediately about their therapy.</p>
<p>Patients should report immediately any evidence of illness, particularly <span class="product-label-link" type="condition" conceptid="26711" conceptname="Chronic pharyngitis">sore throat</span>, <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">skin eruptions</span>, <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>, <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, or <span class="product-label-link" type="condition" conceptid="4272240" conceptname="Malaise">general malaise</span>. They also should report symptoms suggestive of hepatic dysfunction (<span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">anorexia</span>, pruritis, <span class="product-label-link" type="condition" conceptid="194175" conceptname="Left upper quadrant pain">right upper quadrant pain</span>, etc).</p>
</div>
<div class="Section" data-sectionCode="34075-2">
<a name="i4i_lab_tests_id_eb3fe736-82db-4e39-b087-141dbd317b9b"></a><a name="section-7.3"></a><p></p>
<h2>Laboratory Tests</h2>
<p class="First">Because propylthiouracil may cause <span class="product-label-link" type="condition" conceptid="4253058" conceptname="Factor II deficiency">hypoprothrombinemia</span> and <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">bleeding</span>, monitoring of <span class="product-label-link" type="condition" conceptid="4173906" conceptname="Clotting factor II assay">prothrombin</span> time should be considered during therapy with the drug, especially before surgical procedures.</p>
<p><span class="product-label-link" type="condition" conceptid="4261836" conceptname="Thyroid panel">Thyroid function tests</span> should be monitored periodically during therapy. Once clinical evidence of <span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">hyperthyroidism</span> has resolved, the finding of an elevated serum TSH indicates that a lower maintenance dose of propylthiouracil should be employed.</p>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="i4i_interactions_id_d391052b-9e08-4dc2-b1f7-1afbdea128d6"></a><a name="section-7.4"></a><p></p>
<h2>Drug Interactions</h2>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_84d6e311-ca70-41bc-96a7-02ba017a8b3b"></a><a name="section-7.4.1"></a><p></p>
<h3><span class="Italics">Anticoagulants (oral)</span></h3>
<p class="First">Due to the potential inhibition of vitamin K activity by propylthiouracil, the activity of oral anticoagulants (e.g., warfarin) may be increased; additional monitoring of PT/INR should be considered, especially before surgical procedures.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_f455ded1-8a7d-4685-85ce-dd55d348c0c6"></a><a name="section-7.4.2"></a><p></p>
<h3><span class="Italics">Beta-adrenergic blocking agents</span></h3>
<p class="First"><span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">Hyperthyroidism</span> may cause an increased clearance of beta blockers with a high extraction ratio. A reduced dose of beta-adrenergic blockers may be needed when a hyperthyroid patient becomes euthyroid.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_2bf9cbc2-6ba7-4eee-8673-aa606469e040"></a><a name="section-7.4.3"></a><p></p>
<h3><span class="Italics">Digitalis Glycosides</span></h3>
<p class="First">Serum digitalis levels may be increased when hyperthyroid patients on a stable digitalis glycoside regimen become euthyroid; a reduced dosage of digitalis glycosides may be needed.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_6194b528-8005-453e-ae23-f481d2e65528"></a><a name="section-7.4.4"></a><p></p>
<h3><span class="Italics">Theophylline</span></h3>
<p class="First">Theophylline clearance may decrease when hyperthyroid patients on a stable theophylline regimen become euthyroid; a reduced dose of theophylline may be needed.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_9ecf9594-dd91-451c-8f67-22e7a86e12ac"></a><a name="section-7.4.5"></a><p></p>
<h3><span class="Italics">Carcinogenesis, Mutagenesis, Impairment of Fertility</span></h3>
<p class="First">Laboratory animals treated with propylthiouracil for &gt; 1 year have demonstrated <span class="product-label-link" type="condition" conceptid="135772" conceptname="Goiter">thyroid hyperplasia</span> and carcinoma formation<span class="Sup">1</span>. Such animal findings are seen with continuous suppression of thyroid function by sufficient doses of a variety of<span class="Italics"> antithyroid</span> agents, as well as in dietary iodine deficiency, subtotal thyroidectomy, and implantation of autonomous thyrotropic hormone - secreting pituitary tumors. <span class="product-label-link" type="condition" conceptid="437251" conceptname="Benign neoplasm of pituitary gland and craniopharyngeal duct">Pituitary adenomas</span> have also been described.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_92a3accb-65ed-46c0-b724-ea6c5ef1f6c6"></a><a name="section-7.4.6"></a><p></p>
<h3><span class="Italics">Pregnancy</span></h3>
<p class="First"><span class="Italics">Pregnancy Category D. </span>SEE <a href="#i4i_warnings_id_504ebf66-540f-44b4-a05f-b440aae80dd0">WARNINGS</a>.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_0b28d2a3-f5be-4d85-a7b7-39e5d78e48c4"></a><a name="section-7.4.7"></a><p></p>
<h3><span class="Italics">Nursing Mothers</span></h3>
<p class="First">Propylthiouracil is transferred to breasdt milk to a small extent and therefore likely results in clinically insignificant doses to the suckling infant. One one study, nine lactating women were administered 400 mg of propylthiouracil by mouth. The mean amount of propylthiouracil excreted during 4 hours after drug administration was 0.025% of the administered dose.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_88e89f88-0aae-4629-8b63-6324b7da9db2"></a><a name="section-7.4.8"></a><p></p>
<h3><span class="Italics">Pediatric Use</span></h3>
<p class="First">Post-marketing reports of severe <span class="product-label-link" type="condition" conceptid="4352876" conceptname="Liver damage">liver injury</span> including <span class="product-label-link" type="condition" conceptid="4245975" conceptname="Hepatic failure">hepatic failure</span> requiring liver transplantation or resulting in <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span> have been reported in the pediatric population. No such reports have been observed with methimazole. As such, propylthiouracil is not recommended for use in the pediatric population except in rare instances in which methimazole is not well-tolerated and surgery or radioactive iodine therapy are not appropriate.</p>
<p>When used in children, parents and patients should be informed of the risk of <span class="product-label-link" type="condition" conceptid="4245975" conceptname="Hepatic failure">liver failure</span>. If patients taking propylthiouracil develop <span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">tiredness</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">anorexia</span>, <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>, <span class="product-label-link" type="condition" conceptid="4226263" conceptname="Pharyngitis">pharyngitis</span>, or <span class="product-label-link" type="condition" conceptid="4272240" conceptname="Malaise">malaise</span>, propylthiouracil should be discontinued immediately by the patient, a physician should be contacted, and a white blood cell count, liver function tests, and transaminase levels obtained.</p>
</div>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="i4i_adverse_effects_id_ff4afd0c-dda2-4b62-81c3-f0de5d1d449b"></a><a name="section-8"></a><p></p>
<h1>ADVERSE REACTIONS:</h1>
<p class="First">Major adverse reactions (much less common than the minor adverse reactions) include <span class="product-label-link" type="condition" conceptid="4352876" conceptname="Liver damage">liver injury</span> resulting in <span class="product-label-link" type="condition" conceptid="194990" conceptname="Inflammatory disease of liver">hepatitis</span>, <span class="product-label-link" type="condition" conceptid="4245975" conceptname="Hepatic failure">liver failure</span>, a need for liver transplantation or <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span>. Inhibition of myelopoiesis (<span class="product-label-link" type="condition" conceptid="440689" conceptname="Agranulocytosis">agranulocytosis</span>, granulopenia, and <span class="product-label-link" type="condition" conceptid="432870" conceptname="Thrombocytopenic disorder">thrombocytopenia</span>), <span class="product-label-link" type="condition" conceptid="137829" conceptname="Aplastic anemia">aplastic anemia</span>, <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">drug fever</span>, a lupus-like syndrome (including <span class="product-label-link" type="condition" conceptid="200527" conceptname="Splenomegaly">splenomegaly</span> and <span class="product-label-link" type="condition" conceptid="4137275" conceptname="Vasculitis">vasculitis</span>), <span class="product-label-link" type="condition" conceptid="194990" conceptname="Inflammatory disease of liver">hepatitis</span>, periartentis, and <span class="product-label-link" type="condition" conceptid="4253058" conceptname="Factor II deficiency">hypoprothrombinemia</span> and <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">bleeding</span> have been reported. <span class="product-label-link" type="condition" conceptid="193253" conceptname="Nephritis">Nephritis</span>, <span class="product-label-link" type="condition" conceptid="4263367" conceptname="Glomerulonephritis">glomerulonephritis</span>, <span class="product-label-link" type="condition" conceptid="4119786" conceptname="Interstitial lung disease">interstitial pneumonitis</span>, <span class="product-label-link" type="condition" conceptid="4270887" conceptname="Erythroderma">exfoliative dermatitis</span>, and <span class="product-label-link" type="condition" conceptid="140176" conceptname="Erythema nodosum">erythema nodosum</span> have been reported. Reports of a <span class="product-label-link" type="condition" conceptid="4137275" conceptname="Vasculitis">vasculitis</span> syndrome associated with the presence of anti-neutrophilic cytoplasmic antibodies (<span class="product-label-link" type="condition" conceptid="4012393" conceptname="Antiproteinase 3 antibody">ANCA</span>) have also been received. Manifestations of <span class="product-label-link" type="condition" conceptid="4012393" conceptname="Antiproteinase 3 antibody">ANCA</span>-positive <span class="product-label-link" type="condition" conceptid="4137275" conceptname="Vasculitis">vasculitis</span> may include rapidly progressive <span class="product-label-link" type="condition" conceptid="4263367" conceptname="Glomerulonephritis">glomerulonephritis</span> (crescentic and pauci-immune necrotizing <span class="product-label-link" type="condition" conceptid="4263367" conceptname="Glomerulonephritis">glomerulonephritis</span>), sometimes leading to <span class="product-label-link" type="condition" conceptid="197320" conceptname="Acute renal failure syndrome">acute renal failure</span>; pulmonary infiltrates or alveolar <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">hemorrhage</span>; <span class="product-label-link" type="condition" conceptid="4262920" conceptname="Skin ulcer">skin ulcers</span>; and <span class="product-label-link" type="condition" conceptid="196431" conceptname="Hypersensitivity angiitis">leucocytoclastic vasculitis</span>. Minor adverse reactions include <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">skin rash</span>, <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="23325" conceptname="Heartburn">epigastric distress</span>, <span class="product-label-link" type="condition" conceptid="77074" conceptname="Joint pain">arthralgia</span>, <span class="product-label-link" type="condition" conceptid="4193492" conceptname="Acroparesthesia">paresthesias</span>, <span class="product-label-link" type="condition" conceptid="4289517" conceptname="Loss of taste">loss of taste</span>, <span class="product-label-link" type="condition" conceptid="436235" conceptname="Taste sense altered">taste perversion</span>,Â abnormal Ioss of hair, <span class="product-label-link" type="condition" conceptid="442752" conceptname="Muscle pain">myalgia</span>, <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span>, <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span>, <span class="product-label-link" type="condition" conceptid="444252" conceptname="Neuritis">neuritis</span>, <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span>, <span class="product-label-link" type="condition" conceptid="439383" conceptname="Vertigo">vertigo</span>, <span class="product-label-link" type="condition" conceptid="4083855" conceptname="Abnormal pigment">skin pigmentation</span>, <span class="product-label-link" type="condition" conceptid="137977" conceptname="Jaundice">jaundice</span>, sialadenopathy, and <span class="product-label-link" type="condition" conceptid="315085" conceptname="Lymphadenopathy">lymphadenopathy</span>.</p>
<p>It should be noted that about 10% of patients with untreated <span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">hyperthyroidism</span> have <span class="product-label-link" type="condition" conceptid="435224" conceptname="Leukopenia">leukopenia</span> (white blood cell count of less than 4,000/mm<span class="Sup">3</span>), often with relative granulopenia.</p>
<p>To report SUSPECTED ADVERSE REACTIONS, contact West-ward Pharmaceutical Corp. at 1-877-233-2001 or the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="i4i_overdosage_id_3b69b5e9-278d-42b2-92f5-a31e957ee540"></a><a name="section-9"></a><p></p>
<h1>OVERDOSAGE:</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_95e3755a-7532-4bb0-bf21-0aeaaec0fb23"></a><a name="section-9.1"></a><p></p>
<h2><span class="Italics">Signs and Symptoms</span></h2>
<p class="First"><span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">Nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="23325" conceptname="Heartburn">epigastric distress</span>, <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>, <span class="product-label-link" type="condition" conceptid="77074" conceptname="Joint pain">arthralgia</span>, <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span>, <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span>, and <span class="product-label-link" type="condition" conceptid="432881" conceptname="Pancytopenia">pancytopenia</span>. <span class="product-label-link" type="condition" conceptid="440689" conceptname="Agranulocytosis">Agranulocytosis</span> is the most serious effect. Rarely, <span class="product-label-link" type="condition" conceptid="4270887" conceptname="Erythroderma">exfoliative dermatitis</span>, <span class="product-label-link" type="condition" conceptid="194990" conceptname="Inflammatory disease of liver">hepatitis</span>, neuropathies, or CNS stimulation or <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span> may occur.</p>
<p>No information is available on the following: LD<span class="Sub">50</span>: concentration of propylthiouracil in biologic fluids associated with toxicity and/or <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span>; the amount of drug in a single dose usually associated with symptoms of overdosage; or the amount of propylthiouracil in a single dose likely to be life-threatening.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_15a3cac9-46f3-4b5c-9ce1-47db35e676c3"></a><a name="section-9.2"></a><p></p>
<h2><span class="Italics">Treatment </span></h2>
<p class="First">To obtain up-to-date information about the treatment of <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span>, a good resource is the certified Regional Poison Control Center.Â In managing overdosage, consider the possibility of <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">multiple drug overdoses</span>, interaction among drugs, and unusual drug kinetics in the patient.</p>
<p>In the event of an <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span>, appropriate supportive treatment should be initiated as dictated by the patient's medical status.</p>
</div>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="i4i_dosage_admin_id_45bf3df4-70dd-49d2-9954-f6a854fcbc5a"></a><a name="section-10"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION:</h1>
<p class="First">Propylthiouracil is administered orally. The total daily dosage is usually given in 3 equal doses at approximately 8-hour intervals.</p>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_36b9dd36-e1b6-4dd5-b851-570ffe3c16f3"></a><a name="section-10.1"></a><p></p>
<h2><span class="Italics">Adults </span></h2>
<p class="First">The initial dose is 300 mg daily. In patients with severe <span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">hyperthyroidism</span>, very large <span class="product-label-link" type="condition" conceptid="135772" conceptname="Goiter">goiters</span>, or both, the initial dose may be increased to 400 mg daily; an occasional patient will require 600 to 900 mg daily initially. The usual maintenance dose is 100 to 150 mg daily. In general, dose selection for an elderly patient should be cautious, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_1b8dbd32-ab01-43f2-84c8-73cc73ab6ef6"></a><a name="section-10.2"></a><p></p>
<h2><span class="Italics">Pediatric Patients</span></h2>
<p class="First">Propylthiouracil is generally not recommended for use in the pediatric patient population except in rare instances in which other alternative therapies are not appropriate options. Studies evaluating appropriate dosing regimen have not been conducted in the pediatric population although general practice would suggest initiation of therapy in patients 6 years or older at a dosage of 50 mg daily with careful upward titration based on clinical response and evaluation of TSH and free T4 levels. Although cases of severe <span class="product-label-link" type="condition" conceptid="4352876" conceptname="Liver damage">liver injury</span> have been reported with doses as low as 50 mg/day, most cases were associated with doses of 300 mg/day and higher.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_762ead74-be76-42f2-8511-2cb4ba4b6f8d"></a><a name="section-10.3"></a><p></p>
<h2><span class="Italics">Geriatric Use</span></h2>
<p class="First">Clinical studies of propylthiouracil did not include sufficient numbers ofÂ subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. In general, dose selection for an elderly patient should be cautious, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.</p>
</div>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="i4i_how_supplied_id_80408c2a-0d83-42a7-b310-72136b618386"></a><a name="section-11"></a><p></p>
<h1>HOW SUPPLIED:</h1>
<p class="First">Propylthiouracil Tablets, USP, 50 mg: White, Round, Scored Tablet, DebossedÂ â€œWest-ward 480â€?.</p>
<ul><li>Bottles of 30 tablets. </li></ul>
<p>Store at 20-25Â°C (68-77Â°F) [See USP Controlled Room Temperature]. Protect from light and moisture.</p>
<p>Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.</p>
<p>Reference:</p>
<ol><li>International Agency for Research on Cancer, IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man. 1974; 7:67-76.</li></ol>
<p>Manufactured By:<br><span class="Bold">West-ward Pharmaceutical Corp.</span><br>Eatontown, NJ 07724<br>Revised August 2011</p>
<p>Repackaged by:</p>
<p><span class="Bold">Rebel Distributors Corp</span></p>
<p>Thousand Oaks, CA 91320</p>
</div>
<div class="Section" data-sectionCode="42231-1">
<a name="i4i_medguide_id_173a3d44-1103-44e7-a00f-53db10d40123"></a><a name="section-12"></a><p></p>
<h1>MEDICATION GUIDE</h1>
<p class="First"><span class="Bold">PROPYLTHIOURACIL TABLETS, USP (Pro-pil-thi-o-ur-a-sil)</span></p>
<p>Read this Medication Guide before you start taking Propylthiouracil and each time you get a refill. There may be new information. This Medication Guide does not take the place of talking to your doctor about your medical condition or treatment.</p>
<p><span class="Bold">What is the most important information I should know about Propylthiouracil?<br></span>Propythiouracil can cause serious side effects, including:<br><span class="Bold">Severe liver problems</span>. In some cases, these liver problems can lead to <span class="product-label-link" type="condition" conceptid="4245975" conceptname="Hepatic failure">liver failure</span>, the need for liver transplant, or <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span>.</p>
<p><span class="Bold">Stop taking Propylthiouracil and call your doctor right away if you have:</span></p>
<ul>
<li><span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span> </li>
<li>loss of appetite </li>
<li><span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span> </li>
<li><span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span> </li>
<li><span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">tiredness</span> </li>
<li>itchiness </li>
<li><span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span> or <span class="product-label-link" type="condition" conceptid="4082445" conceptname="Tenderness">tenderness</span> in your right upper stomach area (abdomen) </li>
<li>dark (tea colored) urine </li>
<li><span class="product-label-link" type="condition" conceptid="4260836" conceptname="Blanching of skin">pale</span> or light colored bowel movements (stools) </li>
<li>yellowing of your skin or whites of your eyes</li>
</ul>
<p><span class="Bold">What is Propylthiouracil?<br></span>Propylthiouracil is a prescription medicine used to treat people who have Graves' disease with <span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">hyperthyroidism</span> or toxic multinodular <span class="product-label-link" type="condition" conceptid="135772" conceptname="Goiter">goiter</span>. Propylthiouracil is used when:</p>
<ul>
<li>certain other antithyroid medicines do not work well. </li>
<li>thyroid surgery or radioactive iodine therapy is not a treatment option. </li>
<li>to decrease symptoms of <span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">hyperthyroidism</span> in preparation for a thyroidectomy (removal of the thyroid gland) or radioactive iodine therapy.</li>
</ul>
<p>Propylthiouracil is not recommended for use in children.</p>
<p>Propylthiouracil may be used when an antithyroid drug is needed during or just before the first trimester of pregnancy.</p>
<p><span class="Bold">Who should <span class="Italics">not</span> take Propylthiouracil?<br></span>Do not take Propylthiouracil if you are allergic to Propylthiouracil or any of its ingredients. See the end of this Medication Guide for a complete list of ingredients in Propylthiouracil.</p>
<p><span class="Bold">What should I tell my doctor before taking Propylthiouracil?<br></span>Before you take Propylthiouracil, tell your doctor if you:</p>
<ul>
<li>plan to have surgery. </li>
<li>have any other medical conditions. </li>
<li>are pregnant or plan to become pregnant. <ul>
<li>Propylthiouracil may cause liver problems, <span class="product-label-link" type="condition" conceptid="4245975" conceptname="Hepatic failure">liver failure</span> and <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span> in pregnant women. </li>
<li>Propylthiouracil may harm your unborn baby.</li>
</ul>
</li>
<li>are breast-feeding or plan to breast-feed. Propylthiouracil can pass into your breast milk. Talk to you doctor about the best way to feed your baby if you take Propylthiouracil.</li>
</ul>
<p><span class="Bold">Tell your doctor about all the medicines you take, including prescription and nonprescription medicines, vitamins, and herbal supplements. </span>Propylthiouracil may affect the way other medicines work.</p>
<p>Especially, tell your doctor if you take:</p>
<ul>
<li>a blood thinner medicine warfarin sodium (Coumadin, Jantoven) </li>
<li>medicine for heart problems </li>
<li>medicine for high blood pressure </li>
<li>Digoxin (Lanoxicaps, Lanoxin) </li>
<li>Theophylline (Elixophyllin, Theolair, Theochron, Theo-24, Uniphyl)</li>
</ul>
<p>Ask your doctor if you are not sure if your medicine is one of these.<br>Know the medicines you take. Keep a list of them to show your doctor and pharmacist when you get a new medicine.</p>
<p><span class="Bold">How should I take Propylthiouracil?</span></p>
<ul>
<li>Take Propylthiouracil exactly as your doctor tells you to take it. </li>
<li>Your doctor may change your dose if needed. </li>
<li>Propylthiouracil is usually taken 3 times a day (every 8 hours). </li>
<li>If you take too much Propylthiouracil, call your Regional Poison Control Center or go to the nearest hospital emergency room right away. </li>
<li>If you take too much Propylthiouracil you may have the following symptoms: <ul>
<li><span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span> </li>
<li><span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span> </li>
<li>upper <span class="product-label-link" type="condition" conceptid="194175" conceptname="Left upper quadrant pain">stomach pain</span> or <span class="product-label-link" type="condition" conceptid="4082445" conceptname="Tenderness">tenderness</span> </li>
<li><span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span> </li>
<li><span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span> </li>
<li><span class="product-label-link" type="condition" conceptid="77074" conceptname="Joint pain">joint pain</span> </li>
<li><span class="product-label-link" type="condition" conceptid="4275722" conceptname="Swelling">swelling</span> of your body, arms, and legs</li>
</ul>
</li>
<li>If you miss a dose of Propylthiouracil, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose. Just take the next dose at your regular time. Do not double your dose.</li>
</ul>
<p><span class="Bold">What are the possible side effects of Propylthiouracil?<br></span>Propylthiouracil may cause serious side effects, including:</p>
<ul>
<li>
<span class="Bold">liver problems</span>. See "What is the most important information I should know about Propylthiouracil?" </li>
<li>
<span class="Bold">low white blood cell counts. </span>This usually happens within the first 3 months of treatment and can be life-threatening. You may have a higher chance of getting an <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span> when your white blood cell count is low.</li>
</ul>
<p><span class="Bold">Tell your doctor right away if you have:</span></p>
<ul>
<li><span class="Bold">a <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span></span></li>
<li><span class="Bold"><span class="product-label-link" type="condition" conceptid="4190045" conceptname="Rigor">chills</span></span></li>
<li><span class="Bold"><span class="product-label-link" type="condition" conceptid="26711" conceptname="Chronic pharyngitis">sore throat</span></span></li>
<li>
<span class="Bold"><span class="product-label-link" type="condition" conceptid="140673" conceptname="Hypothyroidism">hypothyroidism</span>. </span>Your doctor should do blood tests regularly during treatment to check your thyroid.</li>
<li>increased <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">bleeding</span> especially with surgical procedures and particularly if you are taking blood thinners.</li>
</ul>
<p><span class="Bold">The most common side effects of Propylthiouracil include:</span></p>
<ul>
<li><span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">skin rash</span> or <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">hives</span></li>
<li><span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span></li>
<li><span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span></li>
<li>upper <span class="product-label-link" type="condition" conceptid="194175" conceptname="Left upper quadrant pain">stomach pain</span> or <span class="product-label-link" type="condition" conceptid="4082445" conceptname="Tenderness">tenderness</span></li>
<li><span class="product-label-link" type="condition" conceptid="77074" conceptname="Joint pain">joint pain</span></li>
<li><span class="product-label-link" type="condition" conceptid="4302654" conceptname="Itching">itching</span> or <span class="product-label-link" type="condition" conceptid="4193492" conceptname="Acroparesthesia">tingling</span></li>
<li>loss or change in taste</li>
<li>loss of hair</li>
<li><span class="product-label-link" type="condition" conceptid="442752" conceptname="Muscle pain">muscle pain</span></li>
<li><span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span></li>
<li><span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">sleepiness</span></li>
<li><span class="product-label-link" type="condition" conceptid="373852" conceptname="Neuralgia">nerve pain</span></li>
<li><span class="product-label-link" type="condition" conceptid="4275722" conceptname="Swelling">swelling</span> (<span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span>)</li>
<li><span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span></li>
<li>enlarged salivary glands or enlarged lymph nodes</li>
</ul>
<p>Tell your doctor if you have any side effect that bothers you or that does not go away.</p>
<p>These are not all of the possible side effects of Propylthiouracil. For more information, ask your doctor or pharmacist.</p>
<p>Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.</p>
<p><span class="Bold">How should I store Propylthiouracil?<br></span>Store at 20-25ÂºC (68-77ÂºF) [See USP Controlled Room Temperature].<br><span class="Bold">Keep Propylthiouracil and all medicines out of the reach of children.</span></p>
<p><span class="Bold">General information about the sale and effective use of Propylthiouracil:<br></span>Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide.</p>
<p>Do not use Propylthiouracil for a condition for which it was not prescribed.<br>Do not give Propylthiouracil to other people, even if they have the same symptoms that you have. It may harm them.</p>
<p>This Medication Guide summarizes the most important information about Propylthiouracil. If you would like more information, talk with your doctor. You can ask your pharmacist or doctor for information about Propylthiouracil that is written for health professionals.</p>
<p>West-ward Pharmaceutical Corp.<br> www.west-ward.com <br><span class="Bold">1-877-233-2001</span></p>
<p><span class="Bold">What are the ingredients in Propylthiouracil?<br></span>Active ingredient: propylthiouracil<br>Inactive ingredients: anhydrous lactose, magnesium stearate, microcrystalline cellulose, pregelatinized starch, and sodium starch glycolate.</p>
<p><span class="Bold">West-ward PharmaceuticalÂ Corp.<br></span>Eatontown, NJ 07724 USA</p>
<p>Repackaged by:</p>
<p><span class="Bold">Rebel Distributors Corp</span></p>
<p>Thousand Oaks, CA 91320</p>
<p>This Medication Guide has been approved by the U.S. Food and Drug Administration.<br>04/2010</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="i4i_Principal_display_panel_id_2c417e5e-f19c-4420-82d6-967df18cdd86"></a><a name="section-13"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL</h1>
<p class="First">Propylthiouracil Tablets, USP<br>50 mg/30 Tablets<br>NDC 42254-010-30</p>
<div class="Figure">
<img alt="Propylthiouracil 50mg" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=ff603c99-6620-4945-acdc-c9150b6f77d4&amp;name=ff603c99-6620-4945-acdc-c9150b6f77d4-02.jpg"><p class="MultiMediaCaption"></p>
</div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>PROPYLTHIOURACILÂ 		
					</strong><br><span class="contentTableReg">propylthiouracil tablet</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:42254-010(NDC:0143-1480)</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>PROPYLTHIOURACIL</strong> (PROPYLTHIOURACIL) </td>
<td class="formItem">PROPYLTHIOURACIL</td>
<td class="formItem">50Â mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>ANHYDROUS LACTOSE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>MAGNESIUM STEARATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>CELLULOSE, MICROCRYSTALLINE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>STARCH, CORN</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SODIUM STARCH GLYCOLATE TYPE A POTATO</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">WHITE (WHITE) </td>
<td class="formLabel">Score</td>
<td class="formItem">2 pieces</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">ROUND (ROUND) </td>
<td class="formLabel">Size</td>
<td class="formItem">8mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem">Westward;480</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">Â Â Â Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:42254-010-30</td>
<td class="formItem">30  in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA080154</td>
<td class="formItem">07/23/1971</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler -Â </span>Rebel Distributors Corp.
							(118802834)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Rebel Distributors Corp.</td>
<td class="formItem"></td>
<td class="formItem">118802834</td>
<td class="formItem">RELABEL, REPACK</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 10/2011<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>ff603c99-6620-4945-acdc-c9150b6f77d4</div>
<div>Set id: ff603c99-6620-4945-acdc-c9150b6f77d4</div>
<div>Version: 1</div>
<div>Effective Time: 20111018</div>
</div>
</div>Â <div class="DistributorName">Rebel Distributors Corp.</div></p>
</body></html>
